HATFIELD, PA — Biolyst Scientific has appointed Jay Hexamer as its new Chief Executive Officer, effective immediately, to drive growth and innovation in the company’s next phase of development.
Hexamer, who brings over 30 years of leadership experience in the scientific and life sciences sectors, has a proven track record of steering organizations through expansion and transformation. Most recently, he served as President, CEO, and Senior Advisor at Caron Scientific, where he enhanced global sales and marketing operations and expanded the company’s international footprint. Prior to this, Hexamer held key leadership roles at Avantor, Kimberly-Clark Health Care, and Cardinal Health, overseeing multi-million-dollar operations and implementing strategic initiatives that boosted market presence and operational efficiency.
“I’m honored to join Biolyst Scientific at such an exciting time,” said Hexamer. “The company has a strong legacy of scientific innovation and customer dedication. I look forward to working with the team to accelerate growth and deliver meaningful solutions to our customers worldwide.”
To ensure a smooth leadership transition, Biolyst has established a strategic Advisory Board comprising the founders of Azer Scientific and Electron Microscopy Sciences, the companies that merged to form Biolyst. The board will work closely with Hexamer to guide product development and market strategies.
With Hexamer’s extensive experience and collaborative leadership approach, Biolyst is well-positioned to enhance its market presence and continue offering innovative solutions to its global customer base. Looking ahead, the company aims to deepen its commitment to scientific excellence and achieve sustainable growth in the competitive life sciences sector.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.